Núria Molist‐Brunet

ORCID: 0000-0003-0138-6278
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Chronic Disease Management Strategies
  • Medication Adherence and Compliance
  • Health Systems, Economic Evaluations, Quality of Life
  • Frailty in Older Adults
  • Medieval Architecture and Archaeology
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Archaeological and Historical Studies
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes Management and Research
  • Aging, Health, and Disability
  • Dysphagia Assessment and Management
  • Schizophrenia research and treatment
  • Antibiotic Use and Resistance
  • Adipose Tissue and Metabolism
  • Esophageal and GI Pathology
  • Pneumonia and Respiratory Infections
  • Amyotrophic Lateral Sclerosis Research
  • Pharmacovigilance and Adverse Drug Reactions
  • Health, Medicine and Society
  • Intensive Care Unit Cognitive Disorders
  • Tracheal and airway disorders
  • Nursing care and research
  • Diabetes and associated disorders
  • Restless Legs Syndrome Research

Universitat de Vic - Universitat Central de Catalunya
2016-2025

Parque Sanitario Pere Virgili
2025

Hospital Universitari de Vic
2014-2023

Museu d'Arqueologia de Catalunya
2012-2023

Departamento de Salud
2004-2006

Catalan Society of Family and Community Medicine
2006

Centre d'Higiene Mental Les Corts (Spain)
2006

Collège de France
1974-1981

University of California, San Diego
1981

Grupo Español de Tumores Neuroendocrinos
1979

Objectives 2 innovative concepts have lately been developed to radically improve the care of patients with advanced chronic conditions (PACC): early identification palliative (PC) needs and 3 end-of-life trajectories in illnesses (acute, intermittent gradual dwindling). It is not clear (1) what indicators work best for this (2) if specific clinical exist each these trajectories. The objectives study are explore issues. Setting primary services, an acute hospital, intermediate centre 4...

10.1136/bmjopen-2016-012340 article EN cc-by-nc BMJ Open 2016-09-01

Demographic changes have led to an increase in the number of elderly frail persons and, consequently, systematic geriatric assessment is more important than ever. Frailty Indexes (FI) may be particularly useful discriminate between various degrees frailty but are not routinely assessed due, at least part, large deficits (from 30 70). Therefore, we developed a new, concise FI for rapid (RGA)—the Frail-VIG index (“VIG” Spanish/Catalan abbreviation Comprehensive Geriatric Assessment), which...

10.1186/s12877-018-0718-2 article EN cc-by BMC Geriatrics 2018-01-26

Identifying determinants of medication non-adherence in patients with multimorbidity would provide a step forward developing patient-centered strategies to optimize their care. Medication appropriateness has been proposed play major role non-adherence, reinforcing the importance interdisciplinary review. This study examines factors associated among older and polypharmacy. A cross-sectional non-institutionalized aged ≥65 years ≥2 chronic conditions ≥5 long-term medications admitted an...

10.3390/ijerph18189606 article EN International Journal of Environmental Research and Public Health 2021-09-12

Abstract Background Older patients tend to have multimorbidity, represented by multiple chronic diseases or geriatric conditions, which leads a growing number of prescribed medications. As result, pharmacological prescription has become major concern because the increased difficulties ensure appropriate in older adults. The study’s main objectives were characterize cohort adults with carry out medication review and compare data before after globally according frailty index. Methods This was...

10.1186/s12877-022-03107-2 article EN cc-by BMC Geriatrics 2022-05-12

In persons with dementia, polypharmacy may be discordant the goals of care. It is necessary to design interventions that align treatment regimens patient's situation, prognosis and preferences. The objectives this study conducted at an intermediate care were to: i) identify inappropriate prescribing per main goal; ii) compare pharmacotherapy data pre post a medication review based on degree cognitive impairment; iii) assess implementation proposed recommendations three months after...

10.1186/s12877-025-05783-2 article EN cc-by-nc-nd BMC Geriatrics 2025-02-27

To evaluate the anticholinergic burden (ACB), risk factors associated with its onset and clinical consequences for patients advanced chronic conditions.A 10-month cross-sectional study was carried out in an acute hospital care geriatric unit. Patients conditions were identified by NECessity of PALliative (NECPAL) test. The ACB established using Anticholinergic Drug Scale Burden Index (DBI) tools. Demographic, pharmacological patient data collected objective determining related to ACB....

10.1111/ggi.13330 article EN Geriatrics and gerontology international/Geriatrics & gerontology international 2018-04-11

(1) Background: aging is associated with complex and dynamic changes leading to multimorbidity and, therefore, polypharmacy. A periodic medication review (MR) in frail older people leads optimizing use. The aims of the study were perform a comparative analysis impact place residence (own home versus nursing home) cohort patients on characteristics baseline therapeutic plan after an MR; (2) Methods: Study paired pre- post-MR data based person-centred prescription, follow-up assessment at...

10.3390/ijerph19063423 article EN International Journal of Environmental Research and Public Health 2022-03-14

Abstract Numerous studies have shown that prolactin (PRL) production by GH 3 cells grown in serum supplemented media is regulated several hormones including thyroliberin (TRH). The recent availability of hormonally defined, serum‐free for the growth has made it possible to determine effect TRH absence other regulating hormones. Here we demonstrate transfer /B 6 from serum‐supplemented medium results important changes: (1) altered response TRH, (2) cell attachment and morphology, (3) greatly...

10.1002/jcp.1041090220 article EN Journal of Cellular Physiology 1981-11-01
Coming Soon ...